---
figid: PMC4100211__nihms602385f1
figtitle: Proposed frame work for mRNA nanoparticle mediated tumour vaccination
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
pmcid: PMC4100211
filename: nihms602385f1.jpg
figlink: /pmc/articles/PMC4100211/figure/F1/
number: F1
caption: 'Proposed frame work for mRNA nanoparticle mediated tumour vaccination. A
  combination of three overlapping processes determines immune response: gene delivery,
  immune activation, and major histocompatibility complex (MHC) presentation. In this
  framework, nanoparticles administered into the body have to overcome extracellular
  barriers from the site of administration to antigen presenting cells. After cell
  uptake, nanoparticles have to escape the endosome and mRNA has to unpack from the
  gene carrier and enter the protein translation pathway. At the same time, through
  pattern recognition receptors, mRNA nanoparticle needs to mediate immune activation
  (via TLR3,7/RIG-I,MDA5) so that cytokines are secreted for ensuing adaptive immune
  responses. Protein translated from delivered mRNA molecule needs to enter both the
  MHC I (via proteasome) and II (via lysosome) processing pathways so that antigen
  peptides can be presented on both MHC I and II molecules.'
papertitle: Messenger RNA (mRNA) Nanoparticle Tumour Vaccination.
reftext: Kyle K.L. Phua, et al. Nanoscale. ;6(14):7715-7729.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.7233262
figid_alias: PMC4100211__F1
figtype: Figure
organisms_ner:
- Rattus norvegicus
- Mus musculus
- Homo sapiens
redirect_from: /figures/PMC4100211__F1
ndex: 2f70ecee-df32-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4100211__nihms602385f1.html
  '@type': Dataset
  description: 'Proposed frame work for mRNA nanoparticle mediated tumour vaccination.
    A combination of three overlapping processes determines immune response: gene
    delivery, immune activation, and major histocompatibility complex (MHC) presentation.
    In this framework, nanoparticles administered into the body have to overcome extracellular
    barriers from the site of administration to antigen presenting cells. After cell
    uptake, nanoparticles have to escape the endosome and mRNA has to unpack from
    the gene carrier and enter the protein translation pathway. At the same time,
    through pattern recognition receptors, mRNA nanoparticle needs to mediate immune
    activation (via TLR3,7/RIG-I,MDA5) so that cytokines are secreted for ensuing
    adaptive immune responses. Protein translated from delivered mRNA molecule needs
    to enter both the MHC I (via proteasome) and II (via lysosome) processing pathways
    so that antigen peptides can be presented on both MHC I and II molecules.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Cd4
  - Il2
  - Cd40
  - Tlr3
  - Tlr7
  - Rnf138
  - Myd88
  - Nfkb1
  - Irf3
  - Cd80
  - Cd28
  - Cd70
  - Ifnb1
  - Tnf
  - Il6
  - Il12b
  - Cd27
  - Trav6-3
  - Lamp3
  - Lsamp
  - Rigi
  - Ifih1
  - Trim69
  - Ticam1
  - Ticam2
  - Ifna
  - Il1
  - Cxcl15
  - PARTICL
  - CD4
  - TRBV20OR9-2
  - TRA
  - TRB
  - TRD
  - TRG
  - HLA-C
  - IL2
  - LSAMP
  - LAMP3
  - CD40
  - RIGI
  - TLR3
  - TLR7
  - IFIH1
  - PSMA1
  - PSMA2
  - PSMA3
  - PSMA4
  - PSMA5
  - PSMA6
  - PSMA7
  - PSMA8
  - PSMB1
  - PSMB10
  - PSMB2
  - PSMB3
  - PSMB4
  - PSMB5
  - PSMB6
  - PSMB7
  - PSMB8
  - PSMB9
  - PSMC1
  - PSMC2
  - PSMC3
  - PSMC4
  - PSMC5
  - PSMC6
  - PSMD1
  - PSMD10
  - PSMD11
  - PSMD12
  - PSMD13
  - PSMD14
  - PSMD2
  - PSMD3
  - PSMD4
  - PSMD5
  - PSMD6
  - PSMD7
  - PSMD8
  - PSMD9
  - PSME1
  - PSME2
  - PSME3
  - PSMF1
  - SEM1
  - USP5
  - TRIM69
  - TICAM1
  - MYD88
  - SLC27A4
  - ISYNA1
  - NFKB1
  - IRF3
  - CD8A
  - CD8B
  - CD80
  - CD28
  - CD70
  - IFNK
  - IFNW1
  - IFNA1
  - IFNA2
  - IFNA4
  - IFNA5
  - IFNA6
  - IFNA7
  - IFNA8
  - IFNA10
  - IFNA13
  - IFNA14
  - IFNA16
  - IFNA17
  - IFNA21
  - IFNB1
  - IL1B
  - IL6
  - TNF
  - CXCL8
  - IL12A
  - IL12B
  - CD27
---
